Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:23 de febrero. [Ref.ID 103111]

Anónimo. FDA approves drug to treat multiple myeloma. DIA Daily 2015:17 de noviembre. [Ref.ID 99644]

Anónimo. FDA approves first biosimilar product Zarxio. FDA U.S. Food and Drug Administration 2015:6 de marzo. [Ref.ID 98838]

Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, Pace NL, Apfel CC, on behalf of the Perioperative Clinical Research Core. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ 2011;342:694. [Ref.ID 90343]

Wijeysundera DN, Kavanagh BP. Prevention of pain from propofol injection. BMJ 2011;342:667-8. [Ref.ID 90338]

Aronson JK. Routes of drug administration: uses and adverse effects. Part 1: Intramuscular and subcutaneous injection. Adv Drug React Bull 2008;253:971-4. [Ref.ID 84885]

Krauss B, Green SM. Procedural sedation and analgesia in children. Authors' reply. Lancet 2006;367:1901. [Ref.ID 77192]

Badina L, Norbedo S, Barbi E. Procedural sedation and analgesia in children. Lancet 2006;367:1900-1. [Ref.ID 77191]